Biogen Idec uses cutting-edge science to discover, develop, manufacture and market biological products for the treatment of serious diseases with a focus on neurological disorders.
Founded in 1978, Biogen Idec is the world`s oldest independent biotechnology company. Patients worldwide benefit from its leading multiple sclerosis therapies,
and the company generates more than $4 billion in annual revenues.
Website:www.biogen.com/en_us/home.html
Industries:
Biotechnology
Health Care
Neuroscience
Therapeutics
Investor Types:
Venture Capital
Investment Stages:
Late Stage Venture
Early Stage Venture
Location:
Weston, Massachusetts, United States
Contact information: